MIG - Venture Capital Investor

 

MIG Capital AG uses investments to shape a better tomorrow, today.

 

We manage MIG Fonds, funds used to finance entrepreneurs and start-up businesses in various stages of development.

 

As a venture capital investor, we have already funneled over 600 million Euro into start-up ventures and as such have helped more than 40 outstanding business ideas become a reality.

 

News from MIG Capital AG and the MIG-Portfolio

 

 

MIG Fonds beteiligen sich an Mimi Hearing Technologies

 

Press Release

 

 

MIG Fonds leads 65 million Euro Series B financing of iOmx Therapeutics

 

Press Release

 

 

MIG Fonds sells Hemovent

 

Press release

 

 

MIG portfolio company AMSilk completes €29 million financing round

 

Press release

 

 

MIG AG records 2020 as the most successful year in its company history and aims at further growth

 

Press release

 

 

MIG funds invest in medical technology specialist Creative Balloons

 

Press release

 

 

MIG funds invest in French deep-tech company Zadient Technologies

 

Press release

 

 

MIG funds increases BioNTech dividend payments to a record €600 million

 

Press release

 

 

MIG Fonds invests in German Bionic Systems

 

Press release

 

 

MIG Fonds invest in Dutch start-up Innatera

 

Press release

 

 

150 Million Euro -highest dividend in history of MIG Fonds

 

Press release

 

 

MIG portfolio company Immatics sets course for an IPO

 

Press release

 

 

MIG invests in Neracare

 

Press release

 

 

MIG AG presents a successful financial year 2019

 

Press release

 

 

MIG invests in wealthpilot and Temedica

 

Press release

iqm

 

MIG portfolio company BioNTech starts at Nasdaq.

 

Bell Ringing Ceremony

iqm

 

MIG portfolio company BioNTech raises USD 325 Million in a Series-B-Financing

 

Press release

iqm

 

MIG Fonds invest in Finnish start-up IQM

 

Press release

 

MIG sells all shares of NFON AG

 

Press release

 

MIG AG with excellent Year 2018

 

Press release 

 

MIG invests in Liva Healthcare

 

Press release